WNT7A Human

Wingless-Type MMTV Integration Site Family, Member 7A Human Recombinant
Cat. No.
BT30291
Source
Escherichia Coli.
Synonyms
Wingless-Type MMTV Integration Site Family, Member 7A, Proto-Oncogene Wnt7a Protein, Protein Wnt-7a.
Appearance
Sterile filtered colorless solution.
Purity
Greater than 85.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

WNT7A Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 341 amino acids (32-349 a.a) and having a molecular mass of 38kDa.
WNT7A is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
WNT7A, also known as Wingless-Type MMTV Integration Site Family, Member 7A, is a member of the WNT gene family. This family comprises structurally related genes that encode secreted signaling proteins. These proteins are implicated in oncogenesis and various developmental processes, such as regulating cell fate and patterning during embryogenesis. WNT7A plays a crucial role in developing the anterior-posterior axis in the female reproductive tract. It is also essential for uterine smooth muscle patterning and maintaining adult uterine function. Mutations in WNT7A have been linked to Fuhrmann and Al-Awadi Raas-Rothschild Schinzel phocomelia syndromes.
Description
Recombinant human WNT7A, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 341 amino acids (residues 32-349). It has a molecular mass of 38 kDa. WNT7A is fused to a 23 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
A sterile, colorless solution.
Formulation
The WNT7A protein solution has a concentration of 1 mg/ml and contains 20 mM Tris-HCl buffer (pH 8.0), 10% glycerol, and 0.4 M Urea.
Stability
**Store at 4°C if the entire vial will be used within 2-4 weeks. For longer storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid multiple freeze-thaw cycles.**
Purity
The purity is greater than 85.0% as determined by SDS-PAGE.
Synonyms
Wingless-Type MMTV Integration Site Family, Member 7A, Proto-Oncogene Wnt7a Protein, Protein Wnt-7a.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSLGASIIC NKIPGLAPRQ RAICQSRPDA IIVIGEGSQM GLDECQFQFR NGRWNCSALG ERTVFGKELK VGSREAAFTY AIIAAGVAHA ITAACTQGNL SDCGCDKEKQ GQYHRDEGWK WGGCSADIRY GIGFAKVFVD AREIKQNART LMNLHNNEAG RKILEENMKL ECKCHGVSGS CTTKTCWTTL PQFRELGYVL KDKYNEAVHV EPVRASRNKR PTFLKIKKPL SYRKPMDTDL VYIEKSPNYC EEDPVTGSVG TQGRACNKTA PQASGCDLMC CGRGYNTHQY ARVWQCNCKF HWCCYVKCNT CSERTEMYTC K.

Product Science Overview

Gene Family and Function

The WNT gene family is known for its role in the Wnt signaling pathway, which is essential for regulating cell fate, proliferation, migration, and patterning during embryonic development. WNT7A, in particular, functions as a ligand for members of the frizzled family of seven transmembrane receptors, operating within the canonical Wnt/β-catenin signaling pathway . This pathway is vital for numerous developmental processes, including dorsal-ventral patterning during limb development, skeleton development, and urogenital tract development .

Role in Development and Disease

WNT7A is involved in the development of the anterior-posterior axis in the female reproductive tract and plays a critical role in uterine smooth muscle patterning and maintenance of adult uterine function . Mutations in the WNT7A gene are associated with several congenital disorders, such as Fuhrmann syndrome and Al-Awadi/Raas-Rothschild/Schinzel phocomelia syndromes . These conditions are characterized by limb malformations and other developmental abnormalities.

Research and Applications

Research on WNT7A has shown its potential in targeting Wnt signaling to block angiogenesis and glucose uptake in brain tumors . This highlights the therapeutic potential of modulating Wnt signaling pathways in cancer treatment. Additionally, recombinant WNT7A proteins are used in various research applications to study their role in development and disease.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.